Perhaps timely catching Inspire Medical Systems Inc. (INSP) would be a good idea

Inspire Medical Systems Inc. (NYSE: INSP) stock fell -3.94% on Tuesday to $299.13 against a previous-day closing price of $311.39. With 0.66 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.36 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $312.86 whereas the lowest price it dropped to was $293.48. The 52-week range on INSP shows that it touched its highest point at $314.36 and its lowest point at $157.04 during that stretch. It currently has a 1-year price target of $314.50. Beta for the stock currently stands at 1.42.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of INSP was up-trending over the past week, with a rise of 0.19%, but this was up by 8.57% over a month. Three-month performance surged to 13.63% while six-month performance rose 40.75%. The stock gained 70.06% in the past year, while it has gained 18.76% so far this year. A look at the trailing 12-month EPS for INSP yields -1.54 with Next year EPS estimates of -0.27. For the next quarter, that number is -0.57. This implies an EPS growth rate of -3.70% for this year and 78.90% for next year. EPS is expected to grow by 27.50% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -13.10%.

Float and Shares Shorts:

At present, 29.09 million INSP shares are outstanding with a float of 28.33 million shares on hand for trading. On Apr 27, 2023, short shares totaled 1.25 million, which was 4.30% higher than short shares on Mar 30, 2023. In addition to CNSP as the firm’s CNS Pharmaceuticals, Inc., INSG serves as its Inseego Corp.

Institutional Ownership:

Through their ownership of 98.48% of INSP’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 59.74% of INSP, in contrast to 41.21% held by mutual funds. Shares owned by individuals account for 16.26%. As the largest shareholder in INSP with 9.99% of the stake, The Vanguard Group, Inc. holds 2,901,351 shares worth 2,901,351. A second-largest stockholder of INSP, BlackRock Fund Advisors, holds 1,855,999 shares, controlling over 6.39% of the firm’s shares. Macquarie Investment Management B is the third largest shareholder in INSP, holding 1,060,672 shares or 3.65% stake. With a 3.10% stake in INSP, the Vanguard Total Stock Market ETF is the largest stakeholder. A total of 899,111 shares are owned by the mutual fund manager. The Franklin DynaTech Fund, which owns about 2.75% of INSP stock, is the second-largest Mutual Fund holder. It holds 800,000 shares valued at 214.1 million. Vanguard Small Cap Index Fund holds 2.62% of the stake in INSP, owning 760,100 shares worth 203.43 million.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Mar 30, 2023, INSP reported revenue of $91.39M and operating income of -$14.01M. The EBITDA in the recently reported quarter was -$13.44M and diluted EPS was -$0.53.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for INSP since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With INSP analysts setting a high price target of $360.00 and a low target of $300.00, the average target price over the next 12 months is $313.18. Based on these targets, INSP could surge 20.35% to reach the target high and rise by 0.29% to reach the target low. Reaching the average price target will result in a growth of 4.7% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.

Summary of Insider Activity:

Insiders traded INSP stock several times over the past three months with 21 Buys and 9 Sells. In these transactions, 33,595 shares were bought while 18,128 shares were sold. The number of buy transactions has increased to 60 while that of sell transactions has risen to 51 over the past year. The total number of shares bought during that period was 227,840 while 219,728 shares were sold.

Leave a Comment

Your email address will not be published. Required fields are marked *